Prestige Biopharma』s First-in-Class Pancreatic Cancer Treatment, PBP1510, Receives Approval for Clinical Trial in France

SINGAPORE — (BUSINESS WIRE) — Prestige BioPharma Limited (PBP) specializing in the development of antibody therapeutics, announced that French National Agency for the Safety of Medicines a…